Skip to Content

West-ward 3189 (Lithium Carbonate 300 mg)

Pill with imprint West-ward 3189 is Gray & Yellow, Capsule-shape and has been identified as Lithium Carbonate 300 mg. It is supplied by West-Ward Pharmaceutical Corporation.

Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for West-ward 3189

Lithium Carbonate

Imprint
West-ward 3189
Strength
300 mg
Color
Gray & Yellow
Size
20.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
West-Ward Pharmaceutical Corporation
Inactive Ingredients
magnesium silicate, gelatin, titanium dioxide, butyl alcohol, propylene glycol, ferrosoferric oxide, FD&C Green No. 3, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00143-3189 West-Ward Pharmaceuticals
63739-0265 McKesson Packaging Services
43063-0196 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.